WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:WGBS
CUSIPN/A
Phone+1-510-6514450
Debt
Debt-to-Equity Ratio1.90
Current Ratio1.82
Quick Ratio1.53
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-153.30%
Return on Equity-463.27%
Return on Assets-111.39%
Miscellaneous
Employees54
Outstanding Shares3,790,000
Market Cap$26.12 million
WaferGen Bio-systems (NASDAQ:WGBS) Frequently Asked Questions
What is WaferGen Bio-systems' stock symbol?
WaferGen Bio-systems trades on the NASDAQ under the ticker symbol "WGBS."
How were WaferGen Bio-systems' earnings last quarter?
WaferGen Bio-systems, Inc. (NASDAQ:WGBS) issued its quarterly earnings results on Tuesday, August, 9th. The medical research company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.08. The medical research company had revenue of $2.50 million for the quarter, compared to analyst estimates of $2.60 million. WaferGen Bio-systems had a negative return on equity of 463.27% and a negative net margin of 153.30%. View WaferGen Bio-systems' Earnings History.
Has WaferGen Bio-systems been receiving favorable news coverage?
Media headlines about WGBS stock have been trending somewhat positive on Saturday, according to Accern. The research group rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. WaferGen Bio-systems earned a news impact score of 0.16 on Accern's scale. They also gave news stories about the medical research company an impact score of 46.55 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for WaferGen Bio-systems.
How do I buy shares of WaferGen Bio-systems?
Shares of WGBS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is WaferGen Bio-systems' stock price today?
One share of WGBS stock can currently be purchased for approximately $6.90.
How big of a company is WaferGen Bio-systems?
WaferGen Bio-systems has a market capitalization of $26.12 million. WaferGen Bio-systems employs 54 workers across the globe.
How can I contact WaferGen Bio-systems?
WaferGen Bio-systems' mailing address is 34700 Campus Dr, FREMONT, CA 94555-3612, United States. The medical research company can be reached via phone at +1-510-6514450.
MarketBeat Community Rating for WaferGen Bio-systems (NASDAQ WGBS)
MarketBeat's community ratings are surveys of what our community members think about WaferGen Bio-systems and other stocks. Vote "Outperform" if you believe WGBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WGBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
